Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines.

MLA

Siegfried, Elaine C., et al. “Methotrexate for Inflammatory Skin Disease in Pediatric Patients: Consensus Treatment Guidelines.” Pediatric Dermatology, vol. 40, no. 5, Sept. 2023, pp. 789–808. EBSCOhost, https://doi.org/10.1111/pde.15327.

APA

Siegfried, E. C., Arkin, L. M., Chiu, Y. E., Hebert, A. A., Callen, J. P., Castelo-Soccio, L., Co, D. O., Cordoro, K. M., Curran, M. L., Dalrymple, A. M., Flohr, C., Gordon, K. B., Hanna, D., Irvine, A. D., Kim, S., Kirkorian, A. Y., Lara-Corrales, I., Lindstrom, J., Paller, A. S., … Brandling-Bennett, H. A. (2023). Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines. Pediatric Dermatology, 40(5), 789–808. https://doi.org/10.1111/pde.15327

Chicago

Siegfried, Elaine C, Lisa M Arkin, Yvonne E Chiu, Adelaide A Hebert, Jeffrey P Callen, Leslie Castelo-Soccio, Dominic O Co, et al. 2023. “Methotrexate for Inflammatory Skin Disease in Pediatric Patients: Consensus Treatment Guidelines.” Pediatric Dermatology 40 (5): 789–808. doi:10.1111/pde.15327.